2012
DOI: 10.1089/end.2012.0242
|View full text |Cite
|
Sign up to set email alerts
|

Perioperative Prophylaxis for Percutaneous Nephrolithotomy: Randomized Study Concerning the Drug and Dosage

Abstract: Sulbactam-ampicillin and cefuroxime antibiotics can be used safely for prophylaxis of PCNL. Single dose administration is sufficient.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
32
0
3

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(36 citation statements)
references
References 19 publications
1
32
0
3
Order By: Relevance
“…Previously reported rates of SIRS after PCNL demonstrate a wide range: 9.8%–56.7% [2122]. This variability may be attributed to several causes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previously reported rates of SIRS after PCNL demonstrate a wide range: 9.8%–56.7% [2122]. This variability may be attributed to several causes.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, Dogan et al [25] found no difference in rates of post-PCNL fever in patients who received a single preoperative dose versus a postoperative course extending to nephrostomy tube removal. Seyrek et al [22] prospectively randomized 198 patients to receive a single postoperative dose, an additional dose at 12 hours post-PCNL, or antibiotics until the time of nephrostomy tube removal. The authors found no difference in rates of SIRS between the groups.…”
Section: Discussionmentioning
confidence: 99%
“…Various regimens of antibiotic prophylaxis are implemented to prevent upper urinary system infections and urosepsis (12,13,14). There is a general tendency to apply a short-term antibiotic course, which typically lasts 48 hours after PCNL (15).…”
Section: Discussionmentioning
confidence: 99%
“…The risk of infection in PNL is high and use of ABP has been shown to significantly reduce the risk of infectious complications [351][352][353][354][355][356][357][358][359] (LE: 1b, GR: A). A single dose has shown to be sufficient [360]. Retrograde intra-renal stone treatment could be expected to have a similar risk profile [350].…”
Section: N424 Percutaneous Nephrolithotripsymentioning
confidence: 99%